Cell Therapy Market Size, Growth and Trends Analysis By Type (Autologous & Allogeneic), By Product (Consumables (Vessel/Media/Serum/Reagent), Equipment, & Software & Other Services), Technique, By End User (Hospitals & Clinics & Others) – Forecast till 2027
Cell Therapy Market Scope
Market Research Future (MRFR) believes that the cell therapy market size projected to reach USD 20,217.00 Mn at 22.36% CAGR between 2020 and 2027.
Major Growth Boosters and Challenges
The alarming rise in the number of cancer cases worldwide and the expansive patient base unresponsive to the available alternative treatment options have fostered the demand for the cell therapy industry. Cancer has become one of the deadliest diseases in the world, affecting not only adults but children as well. It requires effective and advanced therapeutic treatments that could better the patient’s quality of life. As a result, the growing focus on the development of highly effective and novel therapies that could address all the symptoms should further enhance the cell therapy industry size worldwide.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/5066
Emergence of highly innovative cell therapies for multiple clinical areas like mantle cell lymphoma (MCL), diffuse large B-cell lymphoma (DLBCL), multiple myeloma (MM), acute lymphoblastic leukemia (ALL), follicular lymphoma (FL), chronic lymphocytic leukemia (CLL), and more should offer growth opportunities to the global cell therapy market. The blossoming population of elderly patients along with the rise in lymphoma and leukemia cases across the globe will also mean significant opportunities for industry participants in the following years.
Cell Therapy Market Segmentation
Major cell therapy types in the market include autologous along with allogeneic. The top spot belongs to the autologous cell therapy segment.
Product-based segments considered in the MRFR study are equipment, consumables (reagent/ vessel/ serum/ media), and software.
Key techniques that have been assessed in the MRFR report are cell vaccine, stem cell therapy, chondrocyte cell therapy, fibroblast cell therapy, and adoptive cell transfer (act).
Technologies covered are genome editing technology, cell immortalization technology, as well as viral vector technology.
The cell sources include bone marrow, adipose tissue, and umbilical cord blood-derived cells. The surge in the number of bone marrow transplantation combined with the mounting number of treatment facilities focused on treating ischemic heart diseases will benefit the market.
Top applications of cell therapy include cardiovascular disease (CVD), re oncology, wound healing and orthopedic.
Cell Therapy Market Regional Status
Cell therapy market geographical distribution covers APAC/Asia Pacific, Europe, MEA/Middle East & Africa as well as the Americas.
Advances in the healthcare industry and new start-ups cropping up rapidly have landed APAC at the top position in the global cell therapy market. Accelerated demand for medications for treating degenerative ailment should also foster the market expansion rate in the region. China is on track to perform tremendously in the coming years, given the rapidly advancing healthcare infrastructure as well as the surge in people’s disposable incomes. The cell therapy market in Asia Pacific is further favored by the government efforts to better the healthcare sector along with the soaring number of research activities based on cell therapy.
The American cell therapy market, by the end of 2027, should account for a 37.6% share and will likely record a notable growth rate of 21.45% during the conjectured period. A large number of renowned healthcare services vendors, especially in the United States, has turned the country the strongest contender in the region. majority of the companies in the region are focused on developing effective therapies for cancer, which is bound to result in substantial revenues in the following years.
The European cell therapy market will cross the valuation of USD 6,357.79 Mn by the end of the given period, establishing itself as a lucrative region. Thanks to the high economic standards and the presence of a well-developed medical infrastructure across Germany, UK, and France, the regional market should expect to grow exponentially in the years to follow. Massive budgets for R&D purposes and healthcare and the disconcerting rise in chronic diseases will also fortify Europe’s position in the global cell therapy market.
Cell Therapy Market Key Players
- Mesoblast Ltd
- Vericel Corporation
- Osiris Therapeutics, Inc
- JCR Pharmaceuticals Co., Ltd
- NuVasive, Inc.
- Pharmicell Co., Ltd
- RTI Surgical Holdings, Inc.
- AlloSource
- Holostem Terapie Avanzate S.r.l.
- Medipost Co., Ltd
are the biggest cell therapy manufacturers in the global market.
These vendors are focused on forming long-term partnerships, alliances, as well as acquisitions to augment their market positions. A few other strategical tactics adopted are considerable investments in research and development activities and expansion of the manufacturing capacity.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/cell-therapy-market-5066
To illustrate, in July 2021, National Resilience Inc. (Resilience) formed an alliance with Bluebird Bio Inc. to accelerate the research, development as well as production of cell therapies. The agreement entails Resilience acquiring Bluebird’s Research Triangle production unit based in North Carolina while retaining over 100 technically skilled staff as well as administrators presently working at the site.
Browse More Related Reports at:
Nutrigenomics Market Size, Share, Trends, Growth | Industry Forecast till 2027
CAR T Cell Therapy Market Size, Growth | Share Analysis, 2027
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
Phone:
+1 628 258 0071(US)
+44 2035 002 764(UK)
Email: sales@marketresearchfuture.com